{"id":1012801,"date":"2026-10-22T16:05:12","date_gmt":"2026-10-22T20:05:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/"},"modified":"2026-10-22T16:05:12","modified_gmt":"2026-10-22T20:05:12","slug":"denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/","title":{"rendered":"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Oct.  22, 2026  (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026.<\/p>\n<p>Denali\u2019s management will host a conference call and webcast on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss third quarter 2026 financial results and provide a general business update.<\/p>\n<p align=\"justify\">The live webcast, along with a slide presentation, may be accessed through the Investors section of Denali\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OT6lCOBW_U7FVVYzjOu-b8SrAk0AlwscGnG7YvqUfyGR05zLege4NDEMM99sdcsTE77sznWSVMufieA9-XkZ15-J-8hIDMesLlUA34wdc-Sl68r_7efyKj2ANqM-U2z3nRK0nSlvVjAyshFE8CB6zM1UBuvPJcKbStOU812IDFv4-vIy77Un7ZyfvY8KtDIyjR5Zjxxp-Y9kFk3-2W40xY6zSdaNw7fliqsOt7AgpMsmdXz4EZNZOE6FdgDqFLPZITICKjP3JLYjF7ZAvAtg--FIOvDpjEVWSWWUYMc-Qng=\" rel=\"nofollow\" target=\"_blank\"><u>www.denalitherapeutics.com<\/u><\/a> or by clicking <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oSIBmDDf5QHr5WHOFZqvHC-EArm5algHEjlPbGP4O6R6u3I01O7u04hEM_CKAKvi9GoRBbhcOlBwkdin90bcuFWFuSswTDUCIR2-To_o_paO-o4GxzzheVm1Qw6Y31b1fdnQNPFl2NjSmmn2spuumBENFrD5bkP5St7xTu3KrtU4DfzJTuxjx-tYPh1inacQHC9iNkgaZOfgvDSOYmDfXjr7eH2tHgse4E8CBMUwe1aFMzQlatSz7CadElzBy-Tm\" rel=\"nofollow\" target=\"_blank\"><u>here<\/u>.<\/a> A replay of the webcast will be archived on Denali\u2019s website for a limited time following the call.<\/p>\n<p>\n        <strong>About<\/strong><br \/>\n        <strong>Denali<\/strong><br \/>\n        <strong>Therapeutics<\/strong>\n      <\/p>\n<p>Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier (BBB) using its proprietary TransportVehicle\u2122 platform. With the first FDA-approved biologic specifically designed to cross the BBB, a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, Denali is advancing toward its goal of delivering effective medicines to transform life for people with neurodegenerative diseases, lysosomal storage disorders and other serious diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OT6lCOBW_U7FVVYzjOu-b8SrAk0AlwscGnG7YvqUfyG3RXadw2cE3mGNfif4d1Nne2Qmt0xHrg9yXLIjrimSN3uVxJBDgOFF12ieh_5ImoP4OMv9pvYSDo8T2t94FJrQkU0D95Vv-eo3UHsBbyBcLmZRp2d-gMn6dKMLbUKJHF37NzaK0NY1jBeKPRSSolGki2lXjNGqrveqPf9p1TzkuEXct2SpKbq67w_Hoxt5yZ234MbkWhlAW1Jay3w0jGNC17y3SLzrDcjyxr3b4IUOhp_rGnJoN-owQE3WbrwWT-yPR98wKIgKTGuMvxIIOqit\" rel=\"nofollow\" target=\"_blank\"><u>www.denalitherapeutics.com<\/u>.<\/a><\/p>\n<p>\n        <strong>Investor Contact: <br \/>Laura Hansen <br \/><\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8tJqCHzP1uulZhxr-MugAR_Hf4N483i00I_6ZxP--9biX3l0ypp5IwihKR4KoP1yN5XyjiL1UvCgQzPK1wd_fg==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>hansen@dnli.com<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTI3MzljMTYtYWFiYi00Njg5LTllOWQtNmY4NGUxYTQwMjUwLTExMDUwMzktMjAyNi0xMC0yMi1lbg==\/tiny\/Denali-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026. Denali\u2019s management will host a conference call and webcast on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss third quarter 2026 financial results and provide a general business update. The live webcast, along with a slide presentation, may be accessed through the Investors section of Denali\u2019s website at www.denalitherapeutics.com or by clicking here. A replay of the webcast will be archived on Denali\u2019s website for a limited time following the call. About Denali Therapeutics &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1012801","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026. Denali\u2019s management will host a conference call and webcast on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss third quarter 2026 financial results and provide a general business update. The live webcast, along with a slide presentation, may be accessed through the Investors section of Denali\u2019s website at www.denalitherapeutics.com or by clicking here. A replay of the webcast will be archived on Denali\u2019s website for a limited time following the call. About Denali Therapeutics &hellip; Continue reading &quot;Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-22T20:05:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026\",\"datePublished\":\"2026-10-22T20:05:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/\"},\"wordCount\":222,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/\",\"name\":\"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=\",\"datePublished\":\"2026-10-22T20:05:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/","og_locale":"en_US","og_type":"article","og_title":"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026. Denali\u2019s management will host a conference call and webcast on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss third quarter 2026 financial results and provide a general business update. The live webcast, along with a slide presentation, may be accessed through the Investors section of Denali\u2019s website at www.denalitherapeutics.com or by clicking here. A replay of the webcast will be archived on Denali\u2019s website for a limited time following the call. About Denali Therapeutics &hellip; Continue reading \"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-22T20:05:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026","datePublished":"2026-10-22T20:05:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/"},"wordCount":222,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/","name":"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=","datePublished":"2026-10-22T20:05:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTQ5MCM3OTEwMjk5IzIwOTM0Njg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-to-report-third-quarter-2026-financial-results-and-business-highlights-on-november-3-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1012801"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012801\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1012801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1012801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1012801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}